Literature DB >> 18167567

Arrhythmogenic right ventricular cardiomyopathy: asymptomatic to life threatening as illustrated by the cases of two sisters.

L C Otterspoor1, C L A Reichert, M J M Cramer, Z A Bhuiyan, A A M Wilde, R N W Hauer.   

Abstract

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a heart muscle disorder of unknown cause that is characterised by fibrofatty replacement, primarily of the right ventricular myocardium, which can lead to life-threatening arrhythmias. It is a disease with a very diverse phenotype. In the present article we describe two sisters, each with a different manifestation of this disorder. The first patient died suddenly at the age of 18 during exercise. Her 17-year-old sister did not have any abnormalities at first cardiac consultation, but a few years later she met several diagnostic criteria for ARVC and an internal cardioverter defibrillator was implanted. Genetic analysis identified a mutation in the plakophilin- 2 (PKP2) gene. Cardiac evaluation of a third sister did not reveal any abnormalities and no mutation in the PKP2 gene was found. Thus, ARVC can vary in its clinical presentation, not only between siblings but also in time. This raises difficulties for the physician for diagnosis, treatment and followup. It is important for the physician involved to consider this disease in patients with palpitations and syncope, especially when there is a family history of ARVC or unexplained sudden death. (Neth Heart J 2007;15:348-53.).

Entities:  

Keywords:  cardiomyopathy; genetics; right ventricle; sudden death

Year:  2007        PMID: 18167567      PMCID: PMC2153466          DOI: 10.1007/BF03086013

Source DB:  PubMed          Journal:  Neth Heart J        ISSN: 1568-5888            Impact factor:   2.380


  22 in total

1.  [Electrocardiology of 4 cases of right ventricular dysplasia inducing arrhythmia].

Authors:  R Frank; G Fontaine; J Vedel; G Mialet; C Sol; G Guiraudon; Y Grosgogeat
Journal:  Arch Mal Coeur Vaiss       Date:  1978-09

2.  Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2).

Authors:  N Tiso; D A Stephan; A Nava; A Bagattin; J M Devaney; F Stanchi; G Larderet; B Brahmbhatt; K Brown; B Bauce; M Muriago; C Basso; G Thiene; G A Danieli; A Rampazzo
Journal:  Hum Mol Genet       Date:  2001-02-01       Impact factor: 6.150

3.  Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy.

Authors:  J Peter van Tintelen; Mark M Entius; Zahurul A Bhuiyan; Roselie Jongbloed; Ans C P Wiesfeld; Arthur A M Wilde; Jasper van der Smagt; Ludolf G Boven; Marcel M A M Mannens; Irene M van Langen; Robert M W Hofstra; Luuk C Otterspoor; Pieter A F M Doevendans; Luz-Maria Rodriguez; Isabelle C van Gelder; Richard N W Hauer
Journal:  Circulation       Date:  2006-03-27       Impact factor: 29.690

4.  Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.

Authors:  P Richardson; W McKenna; M Bristow; B Maisch; B Mautner; J O'Connell; E Olsen; G Thiene; J Goodwin; I Gyarfas; I Martin; P Nordet
Journal:  Circulation       Date:  1996-03-01       Impact factor: 29.690

5.  Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy.

Authors:  Alessandra Rampazzo; Andrea Nava; Sandro Malacrida; Giorgia Beffagna; Barbara Bauce; Valeria Rossi; Rosanna Zimbello; Barbara Simionati; Cristina Basso; Gaetano Thiene; Jeffrey A Towbin; Gian A Danieli
Journal:  Am J Hum Genet       Date:  2002-10-08       Impact factor: 11.025

6.  Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease. Results in patients with inducible and noninducible ventricular tachycardia.

Authors:  T Wichter; M Borggrefe; W Haverkamp; X Chen; G Breithardt
Journal:  Circulation       Date:  1992-07       Impact factor: 29.690

7.  Arrhythmogenic right ventricular cardiomyopathy: asymptomatic to life threatening as illustrated by the cases of two sisters.

Authors:  L C Otterspoor; C L A Reichert; M J M Cramer; Z A Bhuiyan; A A M Wilde; R N W Hauer
Journal:  Neth Heart J       Date:  2007       Impact factor: 2.380

8.  Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.

Authors:  Domenico Corrado; Loira Leoni; Mark S Link; Paolo Della Bella; Fiorenzo Gaita; Antonio Curnis; Jorge Uriarte Salerno; Diran Igidbashian; Antonio Raviele; Marcello Disertori; Gabriele Zanotto; Roberto Verlato; Giuseppe Vergara; Pietro Delise; Pietro Turrini; Cristina Basso; Franco Naccarella; Francesco Maddalena; N A Mark Estes; Gianfranco Buja; Gaetano Thiene
Journal:  Circulation       Date:  2003-11-24       Impact factor: 29.690

9.  Screening for hypertrophic cardiomyopathy in young athletes.

Authors:  D Corrado; C Basso; M Schiavon; G Thiene
Journal:  N Engl J Med       Date:  1998-08-06       Impact factor: 91.245

10.  Screening for ryanodine receptor type 2 mutations in families with effort-induced polymorphic ventricular arrhythmias and sudden death: early diagnosis of asymptomatic carriers.

Authors:  Barbara Bauce; Alessandra Rampazzo; Cristina Basso; Alessia Bagattin; Luciano Daliento; Natascia Tiso; Pietro Turrini; Gaetano Thiene; Gian Antonio Danieli; Andrea Nava
Journal:  J Am Coll Cardiol       Date:  2002-07-17       Impact factor: 24.094

View more
  6 in total

1.  Desmosomal molecules in and out of adhering junctions: normal and diseased States of epidermal, cardiac and mesenchymally derived cells.

Authors:  Sebastian Pieperhoff; Mareike Barth; Steffen Rickelt; Werner W Franke
Journal:  Dermatol Res Pract       Date:  2010-06-30

2.  Arrhythmogenic right ventricular cardiomyopathy: asymptomatic to life threatening as illustrated by the cases of two sisters.

Authors:  L C Otterspoor; C L A Reichert; M J M Cramer; Z A Bhuiyan; A A M Wilde; R N W Hauer
Journal:  Neth Heart J       Date:  2007       Impact factor: 2.380

Review 3.  Mutations with pathogenic potential in proteins located in or at the composite junctions of the intercalated disk connecting mammalian cardiomyocytes: a reference thesaurus for arrhythmogenic cardiomyopathies and for Naxos and Carvajal diseases.

Authors:  Steffen Rickelt; Sebastian Pieperhoff
Journal:  Cell Tissue Res       Date:  2012-03-27       Impact factor: 5.249

4.  Plakophilin-2: a cell-cell adhesion plaque molecule of selective and fundamental importance in cardiac functions and tumor cell growth.

Authors:  Steffen Rickelt
Journal:  Cell Tissue Res       Date:  2012-01-28       Impact factor: 5.249

5.  Arrhythmogenic right ventricular cardiomyopathy in patients with biallelic JUP-associated skin fragility.

Authors:  Hassan Vahidnezhad; Leila Youssefian; Masoomeh Faghankhani; Nikoo Mozafari; Amir Hossein Saeidian; Fatemeh Niaziorimi; Fahimeh Abdollahimajd; Soheila Sotoudeh; Fateme Rajabi; Liaosadat Mirsafaei; Zahra Alizadeh Sani; Lu Liu; Alyson Guy; Sirous Zeinali; Ariana Kariminejad; Reginald T Ho; John A McGrath; Jouni Uitto
Journal:  Sci Rep       Date:  2020-12-10       Impact factor: 4.379

Review 6.  The junctions that don't fit the scheme: special symmetrical cell-cell junctions of their own kind.

Authors:  Werner W Franke; Steffen Rickelt; Mareike Barth; Sebastian Pieperhoff
Journal:  Cell Tissue Res       Date:  2009-08-14       Impact factor: 5.249

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.